AstraZeneca reported $1.09B in Operating Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 5.5B 899M
Alcon AG ALC:SW USD 21M 184M
Amgen AMGN:US USD 2.23B 508M
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 1.09B 151M
AstraZeneca AZN:SS USD 1.09B 151M
Astrazeneca AZN:US USD 1.09B 151M
Bayer BAYN:GR EUR 1.43B 233M
Biogen BIIB:US USD 699.9M 615.2M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Eli Lilly And LLY:US USD 1.84B 159.9M
Fresenius FRE:GR EUR 687M 200M
Fresenius Medical Care FME:GR EUR 352M 119.64M
Genmab GEN:DC DKK 2.66B 734M
Gilead Sciences GILD:US USD 2.27B 570M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Hikma Pharmaceutical HIK:LN USD 60M 189M
Merck MRK:GR EUR 889M 345M
Merk MRK:US USD 3.51B 505M
Novartis NOVN:VX USD 1.95B 219M
Orion ORNBV:FH EUR 40.7M 204.7M
Pfizer PFE:US USD 5.17B 4.24B
Philips PHIA:NA EUR 171M 1.7B
Recordati REC:IM EUR 122.7M 23.57M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Roche Holding ROG:VX 5.93B 5.62B